Objective: To assess the association between the use of multivitamins and prostate cancer mortality.
Methods: A total of 5585 deaths from prostate cancer were identified during 18 years of follow-up of 475,726 men who were cancer-free and provided complete information on multivitamin use at enrollment in the Cancer Prevention Study II (CPS-II) cohort in 1982. Cox proportional hazards modeling was used to measure the association between multivitamin use at baseline and death from prostate cancer and to adjust for potential confounders.
Results: The death rate from prostate cancer was marginally higher among men who took multivitamins regularly (≥15 times/month) compared to non-users (multivariate rate ratio=1.07, 95% CI: 0.99–1.15); this risk was statistically significant only for those multivitamin users who used no additional (vitamin A, C, or E) supplements (multivariate rate ratio=1.15, 95% CI: 1.05–1.26). In addition, risk was greatest during the initial four years of follow-up (1982–1986, multivariate rate ratio=1.12, 95 CI: 0.87–1.46).
Conclusions: Regular multivitamin use was associated with a small increase in prostate cancer death rates in our study, and this association was limited to a subgroup of users.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
LS Balluz SM Lieszak RM Philen J Mulinare (2000) ArticleTitleVitamin and mineral supplement use in the United States Arch Family Med 9 258–262 Occurrence Handle10.1001/archfami.9.3.258
KM Fairfield RH Fletcher (2002) ArticleTitleVitamins for chronic disease prevention in adults J Amer Med Assoc 287 3116–3126 Occurrence Handle10.1001/jama.287.23.3116
DA Bender (2002) ArticleTitleDaily doses of multivitamin tablets Br Med J 325 173–174
US Preventive Services Task Force (2003) Routine vitamin supplementation to prevent cancer and cardiovascular disease: recommendations and rationale. Ann Inter Med 139: 56–70.
Giovannucci E, Stampfer MJ, Colditz GA, Hunter DJ, Fuchs C, Rosner BA, Speizer FE, Willet WC (1998) Multivitamin use, folate, and colon cancer in women in the Nurse’s Health Study. Ann Inter Med 129: 517–524.
EJ Jacobs CJ Connell AV Patel A Chao C Rodriguez J Seymour ML McCullough EE Calle MJ Thun (2001) ArticleTitleMultivitamin use and colon cancer mortality in the cancer prevention study II cohort (United States) Cancer Causes Control 12 927–934 Occurrence Handle10.1023/A:1013716323466 Occurrence Handle11808712
CS Fuchs WC Willet GA Colditz DJ Hunter MJ Stampfer FE Speizer E Giovannucci (2002) ArticleTitleThe influence of folate and multivitamin use on the familial risk of colon cancer in women Cancer Epidemiol Biomarkers Prevent 11 227–234
EJ Jacobs CJ Connell A Chao ML McCullough C Rodriguez MJ Thun EE Calle (2003) ArticleTitleMultivitamin use and colorectal cancer incidence in a US cohort: does timing matter? Amer J Epidemiol 158 621–628 Occurrence Handle10.1093/aje/kwg190
ST Mayne HA Risch R Dubrow W-H Chow MD Gammon TL Vaughan DC Farrow JB Schoenberg JL Stanford H Ahsan AB West H Rotterdam WJ Blot JF Fraumeni SuffixJr (2001) ArticleTitleNutrient Intake and risk of subtypes of oesophageal and gastric cancer Cancer Epidemiol Biomarkers Prevent 10 1055–1062
EJ Jacobs CJ Connell ML McCullough A Chao CR Jonas C Rodriguez EE Calle MJ Thun (2002) ArticleTitleVitamin C, vitamin E, and multivitamin supplement use and stomach cancer mortality in the Cancer Prevention Study II cohort Cancer Epidemiol Biomarkers Prevent 11 35–41
A Jemal T Murray A Samuels A Ghafoor W Ward MJ Thun (2003) ArticleTitleCancer Statistics, 2003 CA Cancer J Clinicians 53 5–26
ML Watkins DJ Erickson MJ Thun J Mulinare CW Heath SuffixJr (2000) ArticleTitleMultivitamin use and mortality in a large prospective study Amer J Epidemiol 152 149–152 Occurrence Handle10.1093/aje/152.2.149
AR Kristal JL Stanford JH Cohen K Wicklund RE Patterson (1999) ArticleTitleVitamin and mineral supplement use is associated with reduced risk of prostate cancer Cancer Epidemiol Biomarkers Prevent 8 887–892
MS Willis FH Wians SuffixJr (2003) ArticleTitleThe role of nutrition in preventing prostate cancer: a review of the proposed mechanism of action of various dietary substances Clin Chim Acta 330 57–83 Occurrence Handle10.1016/S0009-8981(03)00048-2 Occurrence Handle12636926
R Prinz-Langenohl I Fohr K Pietrzik (2001) ArticleTitleBeneficial role for folate in the prevention of colorectal and breast cancer Euro J Cancer 40 98–105
OP Heinonen D Albanes J Virtamo PR Taylor JK Huttunene AM Hartman J Haapakoski N Malila M Rautalahti S Ripatti H Maenpaa L Teerenhovi L Koss M Virolainen BK Edwards (1998) ArticleTitleProstate cancer and supplementation with α-tocopherol and β-carotene: incidence and mortality in a controlled trial J Nat Cancer Inst 90 440–446 Occurrence Handle10.1093/jnci/90.6.440 Occurrence Handle9521168
The ABC Study Group (2003) Incidence of cancer and mortality following a-tocopherol and β-carotene supplementation. A postintervention follow-up. J Amer Med Assoc 290: 476–485
AG Schuurman RA Goldbohm HAM Brants PA Brandt Particlevan den (2002) ArticleTitleA prospective cohort study on intake of retinol, vitamins C and E, and carotenoids and prostate cancer risk (Netherlands) Cancer Causes Control 13 573–582 Occurrence Handle10.1023/A:1016332208339 Occurrence Handle12195647
A Shibata A Paganini-Hill RK Ross BE Henderson (1992) ArticleTitleIntake of vegetables, fruits, beta-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly: a prospective study Br J Cancer 66 673–679 Occurrence Handle1419605
JM Chan MJ Stampfer J Ma EB Rimm WC Willet E Giovannucci (1999) ArticleTitleSupplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States Cancer Epidemiol Biomarkers Prevent 8 893–899
C Rodriguez EJ Jacobs AM Mondul EE Calle ML McCullough MJ Thun (2004) ArticleTitleVitamin E supplements and risk of prostate cancer in US men Cancer Epidemiol Biomarkers Prevent 13 378–382
X-Y Zhao DM Peehl NM Navone D Feldman (2000) ArticleTitle1α,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms Endocrinology 141 2548–2556 Occurrence Handle10.1210/en.141.7.2548 Occurrence Handle10875257
X-Y Zhao LH Ly DM Peehl D Feldman (1999) ArticleTitleInduction of androgen receptor by 1α, 25-dihydroxyvitamin D3 and 9-cis retinoic acid in LNCaP human prostate cancer cells Endocrinology 140 1205–1212 Occurrence Handle10.1210/en.140.3.1205 Occurrence Handle10067845
D Pasquali V Rossi D Prezioso V Gentile V Colantuoni T Lotti A Bellastella AA Sinisi (1999) ArticleTitleChanges in tissue transglutaminase activity and expression during retinoic acid-induced growth arrest and apoptosis in primary cultures of human epithelial prostate cells J Clin Endocrinol Metabol 84 1463–1469 Occurrence Handle10.1210/jc.84.4.1463
GG Schwartz BS Hulka (1990) ArticleTitleIs vitamin D deficiency a risk factor for prostate cancer? Anticancer Res 10 1307–1311 Occurrence Handle2241107
WB Grant (2002) ArticleTitleAn estimate of premature cancer mortality in the US due to inadequate doses of solar ultraviolet-B radiation Cancer 94 1867–1875 Occurrence Handle10.1002/cncr.10427 Occurrence Handle11920550
EH Corder HA Guess BS Hulka GD Friedman M Sadler RT Vollmer B Lobaugh MK Drezner JH Vogelman N Orentreich (1993) ArticleTitleVitamin D and prostate cancer: a prediagnostic study with stored sera Cancer Epidemiol Biomarkers Prevent 5 467–472
MH Ahonen L Tenkanen L Teppo M Hakama P Tuohimaa (2000) ArticleTitleProstate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland) Cancer Causes Control 11 847–852 Occurrence Handle10.1023/A:1008923802001 Occurrence Handle11075874
JM Chan E Giovannucci (2001) ArticleTitleDiary products, calcium, and vitamin D and risk of prostate cancer Epidemiol Rev 23 87–92 Occurrence Handle11588859
H Vainio M Rautalahti (1999) ArticleTitleAn international evaulation of the cancer preventive potential of vitamin A Cancer Epidemiol Biomarkers Prevent 8 107–109
SJ Weinstein TJ Hartman R Stolzenberg-Solomon P Pietinen MJ Barrett PR Taylor J Virtamo D Albanes (2003) ArticleTitleNull association between prostate cancer and serum folate, vitamin B6, vitamin B12, and homocysteine Cancer Epidemiol Biomarkers Prevent 12 1271–1272
J Hultdin B Guelpen ParticleVan A Bergh G Hallmans P Stattin (2005) ArticleTitlePlasma folate vitamin B12, and homocysteine and prostate cancer risk: a prospective study Int J Cancer 113 819–824 Occurrence Handle10.1002/ijc.20646 Occurrence Handle15499634
S-W Choi JB Mason (2002) ArticleTitleFolate status: Effects on pathways of colorectal carcinogenesis J Nutri 132 2413S–2418S
M Eichholzer J Luthy U Moser B Fowler (2001) ArticleTitleFolate and the risk of colorectal, breast and cervix cancer: the epidemiological evidence Swiss Med Weekly 131 539–549
SD Stellman L Garfinkel (1986) ArticleTitleSmoking habits and tar levels ina new American Cancer Society prospective study of 1.2 million men and women J Nat Cancer Inst 76 1057–1063 Occurrence Handle3458944
L Garfinkel (1985) ArticleTitleSelection, follow-up, and analysis in the American Cancer Society prospective studies Natl Cancer Inst Monographs 67 49–52
EE Calle DD Terrell (1993) ArticleTitleUtility of the National Death Index for ascertainment of mortality among cancer prevention study II participants Amer J Epidemiol 137 235–241
InstitutionalAuthorNameWorld Health Organization (1977) International classification of diseases World Health Organization Geneva
InstitutionalAuthorNameWorld Health Organization (1999) International classification of diseases World Health Organization Geneva
D Cox (1972) ArticleTitleRegression models and life tables J Roy Statist Soc 34 187–220
GG Kleinbaum LL Kupper H Morgenstern (1982) Epidemiologic Research: Principles and Quantitative Methods Van Nostrand Reinhold New York
KC Chu RE Tarone HP Freeman (2003) ArticleTitleTrends in prostate cancer mortality among Black men and white men in the United States Cancer 97 1507–1516 Occurrence Handle10.1002/cncr.11212 Occurrence Handle12627516
DM Peehl D Feldman (2003) ArticleTitleThe role of vitamin D and retinoids in controlling prostate cancer progression Endocrine-Relat Cancer 10 131–140 Occurrence Handle10.1677/erc.0.0100131
BT Heijmans JMA Boer HED Suchiman CJ Cornelisse RGJ Westendorp D Kromhouf EJM Feskens PE Slagboom (2003) ArticleTitleA common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer Cancer Res 63 1249–1253 Occurrence Handle12649184
F Kimura KH Franke C Steinhoff K Golka HC Roemer AG Anastasiadis WA Schulz (2000) ArticleTitleMethyl group metabolism gene polymorphisms and susceptibility to prostatic carcinoma Prostate 45 225–231 Occurrence Handle10.1002/1097-0045(20001101)45:3<225::AID-PROS4>3.0.CO;2-7 Occurrence Handle11074524
MS Cicek NL Nock DV Conti G Casey JS Witte (2004) ArticleTitleRelationship between methylenetetrahydrofolate reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressiveness Cancer Epidemiol Biomarkers Prevent 13 1331–1338
Rights and permissions
About this article
Cite this article
Stevens, V.L., McCullough, M.L., Diver, W.R. et al. Use of multivitamins and prostate cancer mortality in a large cohort of US men. Cancer Causes Control 16, 643–650 (2005). https://doi.org/10.1007/s10552-005-0384-5
- prostate cancer
- cohort studies